Repeatability of tumor blood flow quantification with (82)Rubidium PET/CT in prostate cancer — a test-retest study

BACKGROUND: Non-invasive tumor blood flow (TBF) quantification is a candidate approach for risk stratification and monitoring of prostate cancer patients. Validation data have recently been published on prostate TBF measurement with the widely used positron emission tomography (PET) flow tracer (82)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochumsen, Mads Ryø, Bouchelouche, Kirsten, Nielsen, Katrine Bødkergaard, Frøkiær, Jørgen, Borre, Michael, Sörensen, Jens, Tolbod, Lars Poulsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609677/
https://www.ncbi.nlm.nih.gov/pubmed/31273483
http://dx.doi.org/10.1186/s13550-019-0529-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609677/
https://www.ncbi.nlm.nih.gov/pubmed/31273483
http://dx.doi.org/10.1186/s13550-019-0529-2

Ejemplares similares